Cargando…

Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic

BACKGROUND: Face and facial expression recognition abilities have been frequently evaluated in the assessment of social cognition disorders in patients with MS. Investigation of the effect of new difficulties emerging in the field of face recognition with the widespread use of masks during the ongoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuzu Kumcu, Müge, Tezcan Aydemir, Sabiha, Ölmez, Büşra, Durmaz Çelik, Nazlı, Yücesan, Canan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731218/
https://www.ncbi.nlm.nih.gov/pubmed/34988718
http://dx.doi.org/10.1007/s10072-021-05797-9
_version_ 1784627311916613632
author Kuzu Kumcu, Müge
Tezcan Aydemir, Sabiha
Ölmez, Büşra
Durmaz Çelik, Nazlı
Yücesan, Canan
author_facet Kuzu Kumcu, Müge
Tezcan Aydemir, Sabiha
Ölmez, Büşra
Durmaz Çelik, Nazlı
Yücesan, Canan
author_sort Kuzu Kumcu, Müge
collection PubMed
description BACKGROUND: Face and facial expression recognition abilities have been frequently evaluated in the assessment of social cognition disorders in patients with MS. Investigation of the effect of new difficulties emerging in the field of face recognition with the widespread use of masks during the ongoing COVID-19 pandemic on patients with MS may make new contributions to the literature. MATERIAL AND METHODS: The study included 44 patients with relapsing–remitting MS (RRMSp) and 51 controls who were matched to the case group in terms of age and education level. The Benton face recognition test-short form (BFRT-sf), Beck Depression Inventory, a close-ended 13-item survey on face recognition difficulties due to mask use during the pandemic was administered to all groups. RESULTS: In the RRMSp, the mean disease duration was 8.2 ± 5.6, the mean EDSS score was 1.2 ± 1.0, and the mean MOCA test score was 27.23 ± 2.08. The mean BFRTsf was 19.9 ± 2.4 in the RRMSp and 21.6 ± 1.8 in the healthy controls.Twenty-five percent of RRMSp and 4% of the healthy controls required people to remove their masks to be able to recognize their faces. Improvement in face recognition difficulty over time was reported as 80% in the healthy controls and 34% in the RRMSp. CONCLUSION: RRMSp had worse performance in masked face recognition and required removal of the facial masks more often than healthy controls to recognize the faces. RRMS patients did not show as much improvement in recognizing masked faces over time according to the onset of the pandemic as healthy controls.
format Online
Article
Text
id pubmed-8731218
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-87312182022-01-06 Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic Kuzu Kumcu, Müge Tezcan Aydemir, Sabiha Ölmez, Büşra Durmaz Çelik, Nazlı Yücesan, Canan Neurol Sci Covid-19 BACKGROUND: Face and facial expression recognition abilities have been frequently evaluated in the assessment of social cognition disorders in patients with MS. Investigation of the effect of new difficulties emerging in the field of face recognition with the widespread use of masks during the ongoing COVID-19 pandemic on patients with MS may make new contributions to the literature. MATERIAL AND METHODS: The study included 44 patients with relapsing–remitting MS (RRMSp) and 51 controls who were matched to the case group in terms of age and education level. The Benton face recognition test-short form (BFRT-sf), Beck Depression Inventory, a close-ended 13-item survey on face recognition difficulties due to mask use during the pandemic was administered to all groups. RESULTS: In the RRMSp, the mean disease duration was 8.2 ± 5.6, the mean EDSS score was 1.2 ± 1.0, and the mean MOCA test score was 27.23 ± 2.08. The mean BFRTsf was 19.9 ± 2.4 in the RRMSp and 21.6 ± 1.8 in the healthy controls.Twenty-five percent of RRMSp and 4% of the healthy controls required people to remove their masks to be able to recognize their faces. Improvement in face recognition difficulty over time was reported as 80% in the healthy controls and 34% in the RRMSp. CONCLUSION: RRMSp had worse performance in masked face recognition and required removal of the facial masks more often than healthy controls to recognize the faces. RRMS patients did not show as much improvement in recognizing masked faces over time according to the onset of the pandemic as healthy controls. Springer International Publishing 2022-01-06 2022 /pmc/articles/PMC8731218/ /pubmed/34988718 http://dx.doi.org/10.1007/s10072-021-05797-9 Text en © Fondazione Società Italiana di Neurologia 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Covid-19
Kuzu Kumcu, Müge
Tezcan Aydemir, Sabiha
Ölmez, Büşra
Durmaz Çelik, Nazlı
Yücesan, Canan
Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
title Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
title_full Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
title_fullStr Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
title_full_unstemmed Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
title_short Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
title_sort masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing covid-19 pandemic
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731218/
https://www.ncbi.nlm.nih.gov/pubmed/34988718
http://dx.doi.org/10.1007/s10072-021-05797-9
work_keys_str_mv AT kuzukumcumuge maskedfacerecognitioninpatientswithrelapsingremittingmultiplesclerosisduringtheongoingcovid19pandemic
AT tezcanaydemirsabiha maskedfacerecognitioninpatientswithrelapsingremittingmultiplesclerosisduringtheongoingcovid19pandemic
AT olmezbusra maskedfacerecognitioninpatientswithrelapsingremittingmultiplesclerosisduringtheongoingcovid19pandemic
AT durmazceliknazlı maskedfacerecognitioninpatientswithrelapsingremittingmultiplesclerosisduringtheongoingcovid19pandemic
AT yucesancanan maskedfacerecognitioninpatientswithrelapsingremittingmultiplesclerosisduringtheongoingcovid19pandemic